Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Annals of Nuclear Medicine
|
August 1, 1994
In vivo kinetics of 99mTc labeled recombinant tissue plasminogen activator in rabbits
K Itoh, M Ieko, E Hiraguchi, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 23, 2004
Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis
M Ieko, T Tarumi, M Takeda, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 4, 2013
Index of circulating anticoagulant cut-off value establishment in activated partial thromboplastin time mixing test for lupus anticoagulant diagnosis
O Kumano, M Ieko, S Naito, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 12, 2016
Rapid remission of severe pain from livedoid vasculopathy by apixaban
Y Yamaguchi, S Nakazato, K Izumi, et al.
Modern Rheumatology
|
January 4, 2014
The inhibition of protein C anticoagulant activity by anti-β2-glycoprotein I (β2GPI) antibodies isolated from patients with antiphospholipid syndrome by chromatography methods
M Ieko, T Nakabayashi, M Takeda, et al.
American Journal of Hematology
|
September 1, 1990
Effect of a factor VIII concentrate on type IIB von Willebrand's disease-associated thrombocytopenia presenting during pregnancy in identical twin mothers
M Ieko, S Sakurama, A Sagawa, et al.
British Journal of Rheumatology
|
February 11, 1999
Haemophagocytic syndrome in a patient with dermatomyositis
S Yasuda, A Tsutsumi, T Nakabayashi, et al.
Annals of Nuclear Medicine
|
July 1, 1991
Tc-99m labeled tissue-type plasminogen activator: preparation, stability and preliminary imaging of thrombus-bearing rats
K Itoh, E Tsukamoto, T Nishibe, et al.
Arthritis and Rheumatism
|
January 27, 1999
Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies
M Ieko, K Ichikawa, D A Triplett, et al.
Seminars in Thrombosis and Hemostasis
|
May 11, 2000
Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis
M Ieko, K Ichikawa, T Atsumi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Annals of Nuclear Medicine
|
August 1, 1994
In vivo kinetics of 99mTc labeled recombinant tissue plasminogen activator in rabbits
K Itoh, M Ieko, E Hiraguchi, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 23, 2004
Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis
M Ieko, T Tarumi, M Takeda, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 4, 2013
Index of circulating anticoagulant cut-off value establishment in activated partial thromboplastin time mixing test for lupus anticoagulant diagnosis
O Kumano, M Ieko, S Naito, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 12, 2016
Rapid remission of severe pain from livedoid vasculopathy by apixaban
Y Yamaguchi, S Nakazato, K Izumi, et al.
Modern Rheumatology
|
January 4, 2014
The inhibition of protein C anticoagulant activity by anti-β2-glycoprotein I (β2GPI) antibodies isolated from patients with antiphospholipid syndrome by chromatography methods
M Ieko, T Nakabayashi, M Takeda, et al.
American Journal of Hematology
|
September 1, 1990
Effect of a factor VIII concentrate on type IIB von Willebrand's disease-associated thrombocytopenia presenting during pregnancy in identical twin mothers
M Ieko, S Sakurama, A Sagawa, et al.
British Journal of Rheumatology
|
February 11, 1999
Haemophagocytic syndrome in a patient with dermatomyositis
S Yasuda, A Tsutsumi, T Nakabayashi, et al.
Annals of Nuclear Medicine
|
July 1, 1991
Tc-99m labeled tissue-type plasminogen activator: preparation, stability and preliminary imaging of thrombus-bearing rats
K Itoh, E Tsukamoto, T Nishibe, et al.
Arthritis and Rheumatism
|
January 27, 1999
Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies
M Ieko, K Ichikawa, D A Triplett, et al.
Seminars in Thrombosis and Hemostasis
|
May 11, 2000
Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis
M Ieko, K Ichikawa, T Atsumi, et al.
Page
of 5